EMA news and press releases
Quelle: RSS-Newsfeed der European Medicines Agency (EMA)
Update as of 25 May 2022:On 24 May 2022, the European Commission issued a legal decision confirming the suspension of the marketing authorisations of HES...
[Veröffentlicht: 25.05.2022 12:00]
EMA business hours over Ascension Day holidays, 26 and 27 May, , 24/05/2022
The European Medicines Agency's (EMA) office is closed from 18:30 on Wednesday 25 May 2022 until 07:30 on Monday 30 May 2022.Essential work related to...
[Veröffentlicht: 24.05.2022 11:40]
EMA guidance supports development of new antibiotics, , 24/05/2022
As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline on...
[Veröffentlicht: 24.05.2022 10:30]
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022, CHMP, 20/05/2022
Nine new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended nine medicines for approval at its May 2022 meeting.A...
[Veröffentlicht: 20.05.2022 12:10]
First treatment for children with Progeria or progeroid like syndromes (rare premature aging syndromes), CHMP, 20/05/2022
EMA has recommended granting a marketing authorisation in the European Union (EU) under exceptional circumstances for Zokinvy (lonafarnib), a treatment...
[Veröffentlicht: 20.05.2022 12:00]
First therapy to treat rare genetic nervous system disorder AADC deficiency, CHMP, 20/05/2022
EMA has recommended granting a marketing authorisation in the European Union (EU) for Upstaza (eladocagene exuparvovec), a therapy for the treatment of...
[Veröffentlicht: 20.05.2022 12:00]
Synchron Research Service: suspension of medicines over flawed studies, CHMP, 20/05/2022
EMA’s human medicines committee (CHMP) has recommended the suspension of the marketing authorisations of several generic medicines tested by Synchron...
[Veröffentlicht: 20.05.2022 12:00]
First therapy to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder, CHMP, 20/05/2022
EMA has recommended granting a marketing authorisation in the European Union (EU) for Xenpozyme (olipudase alfa), a therapy for the treatment of non-...
[Veröffentlicht: 20.05.2022 12:00]
International regulators and WHO: support healthcare professionals to enhance public confidence in COVID-19 vaccines, , 17/05/2022
EMA has endorsed a statement for healthcare professionals jointly developed by the International Coalition of Medicines Regulatory Authorities (ICMRA) ...
[Veröffentlicht: 17.05.2022 14:17]
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 2022, CVMP, 13/05/2022
The Committee elected Mr Gerrit Johan Schefferlie from the Netherlands as its new Chair for a 3-year mandate.CVMP opinions on veterinary medicinal...
[Veröffentlicht: 13.05.2022 15:20]
Gerrit Johan Schefferlie elected new Chair of EMA Committee for Veterinary Medicinal Products (CVMP), CVMP, 13/05/2022
At its May 2022 meeting, the European Medicines Agency’s (EMA) Committee for Veterinary Medicinal Products (CVMP) elected Gerrit Johan...
[Veröffentlicht: 13.05.2022 15:19]
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022, PRAC, 06/05/2022
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of...
[Veröffentlicht: 06.05.2022 11:46]
EMA business hours on Europe Day, Monday 9 May, , 05/05/2022
The European Medicines Agency's (EMA) office is closed from 18:30 on Friday 6 May 2022 until 07:30 on Tuesday 10 May 2022.Essential work related to the...
[Veröffentlicht: 05.05.2022 09:20]
European Immunization Week 2022: Statement by Executive Director Emer Cooke - Why vaccines contribute to a “Long Life for All”, , 25/04/2022
The European Immunization Week, which takes place every year between 24 and 30 April, is a great opportunity to remind ourselves how lucky we...
[Veröffentlicht: 25.04.2022 13:44]
EMA business hours over King's Day holiday, , 25/04/2022
The European Medicines Agency's (EMA) office is closed from 18:30 on Tuesday 26 April 2022 until 07:30 on Thursday 28 April 2022.Essential work related...
[Veröffentlicht: 25.04.2022 09:42]
